Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.26
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.33
5.97%
Pre-market: Aug 18, 2025, 07:10 AM EDT

Barinthus Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.8M 5.8M 20.34M 5.37M 5.7M 6.17M 7.26M 13.42M 30.15M 44.7M 38.24M 32.1M 15.07M 268K 622.26K 3.85M 4.33M
Cost of Revenue
4.37M 5.8M 5.83M 5.81M 5.96M 4.53M 3.08M 1.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
15.06M 13.63M 14.66M -441K -258K 1.64M 4.17M 11.8M 30.15M 44.7M 38.24M 32.1M 15.07M 268K 622.26K 3.85M 4.33M
Operating Income
-71.66M -67.97M -64.57M -71.29M -79.34M -83.91M -89.96M -66.62M -27.05M -4.91M 4.46M -8.31M -38.4M -45.22M -38.19M -34.08M -21.57M
Interest Income
2.46M 2.68M 2.62M 2.18M 2.07M 2.88M 3.63M 4.47M 4.62M 3.11M 1.79M 752K 83K 2K 2.27K 2.27K 2.27K
Pretax Income
-65.35M -61.23M -58.75M -65.33M -73.34M -76.52M -81.59M -59.33M -19.6M 850K 8.89M -3.23M -33.98M -51.14M -46.43M -41.66M -29.34M
Net Income
-65.22M -61.06M -57.83M -63.78M -70.66M -73.35M -77.24M -54.93M -15.43M 5.34M 11.42M -1.38M -33M -50.87M -46.21M -41.49M -29.15M
Selling & General & Admin
34.95M 28.31M 38.99M 26.53M 33.82M 39.96M 46.53M 34.76M 15.19M 6.71M -3.81M 8.19M 27M 25.12M 22.75M 22.55M 11.15M
Research & Development
35.71M 38.84M 38.45M 41.86M 43.88M 41.41M 47.67M 44.2M 40.11M 41.11M 34.68M 27.63M 22.37M 16.37M 12.98M 11.65M 11.22M
Other Expenses
12.18M 12.6M 1.35M 2.15M 2.69M 2.3M 1.76M 559K 553K 553K 553K 553K -3K -3K -3K -3K n/a
Operating Expenses
87.66M 82.74M 77.33M 67.88M 77.24M 83.51M 95.93M 80.68M 57.01M 48.37M 31.43M 36.37M 49.37M 41.49M 35.73M 34.2M 22.36M
Interest Expense
54K 53K 48.06K 38.06K 40.06K 28.06K 43.16K 36.16K 29.16K 103.16K 99K 99K 92K 2.67M 5.28M 6.25M 6.25M
Selling & Marketing Expenses
-1.36M -1.36M -1.24M -1.24M 118K 118K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
81.59M 77.9M 86.24M 76.79M 84.48M 88.36M 94.77M 79.52M 55.85M 48.37M 31.43M 36.37M 49.37M 41.49M 35.73M 34.2M 22.36M
Income Tax Expense
-29K -638K -1.47M -2.07M -3.2M -3.08M -4.27M -4.34M -4.12M -4.47M -2.42M -1.75M -826K -28K 35.01K 42.01K 30.01K
Shares Outstanding (Basic)
40.27M 39.35M 39.42M 39.04M 38.77M 38.6M 38.53M 38.41M 38.01M 37.68M 37.25M 37.2M 37.19M n/a 34.84M 24.9M 34.06M
Shares Outstanding (Diluted)
40.27M 39.35M 39.42M 39.04M 38.77M 38.6M 38.53M 38.41M 38.01M 37.68M 38.16M 38.17M 38.35M n/a 34.84M 24.9M 34.06M
EPS (Basic)
-1.64 -1.55 -1.49 -1.65 -1.84 -1.92 -2.03 -1.44 -0.4 0.15 0.71 0.36 -0.7 -1.22 -1.22 2.23 -72.44
EPS (Diluted)
-1.64 -1.55 -1.49 -1.65 -1.84 -1.92 -2.03 -1.44 -0.41 0.14 0.70 0.35 -0.7 -1.22 -1.22 2.23 -72.44
EBITDA
-58.89M -55.37M -52.89M -59.49M -67.66M -71.06M -75.5M -53.6M -14.18M 6.09M 12.38M -768K -32.41M -47.87M -40.81M -35.1M -22.84M
EBIT
-65.3M -61.17M -58.7M -65.29M -73.3M -76.49M -80.67M -58.48M -18.75M 1.77M 8.93M -3.13M -33.89M -48.47M -41.15M -35.41M -23.09M
Depreciation & Amortization
6.42M 5.82M 5.83M 5.81M 5.64M 5.44M 5.17M 4.89M 4.57M 4.3M 3.44M 2.35M 1.47M 601.73K 337.13K 307.51K 251.72K